The present application relates to a modified release composition comprising nicergoline, or its pharmaceutically acceptable salt thereof, at least one rate-controlling polymer and one or more other pharmaceutically acceptable excipients. The present application also relates to a modified release composition that provides steady plasma concentrations with minimal fluctuations and offer convenient dosing (i.e., dosed less frequently).
